(CNY) HSBC MSCI China - Ratings and Ratios

Exchange: PA • Country: France • Currency: EUR • Type: Etf • ISIN: IE00B44T3H88

Chinese, Equities, Diversified, Exposure, Market

Description: CNY HSBC MSCI China

The HSBC MSCI China UCITS ETF (CNY) is an exchange-traded fund that tracks the Morningstar China TME NR USD index, providing investors with exposure to the Chinese equity market. With its domicile in France, this ETF is designed to cater to investors seeking to tap into Chinas growth potential.

From a technical standpoint, the ETFs price is currently at 6.42, slightly below its 20-day simple moving average (SMA) of 6.51, indicating a potential short-term bearish trend. However, its 50-day SMA is at 6.42, suggesting a stable medium-term outlook. The 200-day SMA at 6.33 provides a bullish long-term indication. The average true range (ATR) of 0.09 (1.44%) suggests moderate volatility. Given these technical indicators, a potential trading range could be between 6.20 and 6.60.

Fundamentally, the ETF has assets under management (AUM) of 924.73 million EUR, indicating a reasonable level of investor interest. As the fund tracks the Morningstar China TME NR USD index, its performance is closely tied to the overall Chinese equity market. Chinas economic growth, driven by factors such as government initiatives, technological advancements, and increasing consumer spending, is likely to positively impact the ETFs performance.

Combining both technical and fundamental analysis, a forecast for the HSBC MSCI China UCITS ETF (CNY) could be as follows: Given the current technical indicators and the ETFs tracking of the Chinese equity market, we could see the price stabilize around 6.40-6.50 in the short term. If the Chinese economy continues to grow and investor sentiment remains positive, the ETF could potentially break through the 52-week high of 7.34 in the long term, reaching 7.80 or higher. Conversely, if theres a downturn in the Chinese market or global economic conditions deteriorate, the price could fall towards the 52-week low of 4.90. Therefore, investors should closely monitor both the technical trends and fundamental factors influencing the Chinese equity market.

Additional Sources for CNY ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CNY ETF Overview

Market Cap in USD 1,089m
Category China Equity
TER 0.28%
IPO / Inception 2011-01-26

CNY ETF Ratings

Growth Rating -14.1
Fundamental -
Dividend Rating 61.2
Rel. Strength 10.3
Analysts -
Fair Price Momentum 6.30 EUR
Fair Price DCF -

CNY Dividends

Dividend Yield 12m 3.01%
Yield on Cost 5y 2.43%
Annual Growth 5y 18.14%
Payout Consistency 88.5%
Payout Ratio %

CNY Growth Ratios

Growth Correlation 3m 43.3%
Growth Correlation 12m 70.3%
Growth Correlation 5y -63.8%
CAGR 5y -3.86%
CAGR/Max DD 5y -0.07
Sharpe Ratio 12m -0.27
Alpha 15.09
Beta 0.583
Volatility 21.64%
Current Volume 25.3k
Average Volume 20d 21.9k
Stop Loss 6.3 (-3.2%)
What is the price of CNY shares?
As of July 09, 2025, the stock is trading at EUR 6.51 with a total of 25,349 shares traded.
Over the past week, the price has changed by +0.51%, over one month by -2.12%, over three months by +11.12% and over the past year by +26.33%.
Is HSBC MSCI China a good stock to buy?
Neither. Based on ValueRay´s Analyses, HSBC MSCI China is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -14.11 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CNY is around 6.30 EUR . This means that CNY is currently overvalued and has a potential downside of -3.23%.
Is CNY a buy, sell or hold?
HSBC MSCI China has no consensus analysts rating.
What are the forecasts for CNY share price target?
According to our own proprietary Forecast Model, CNY HSBC MSCI China will be worth about 7.1 in July 2026. The stock is currently trading at 6.51. This means that the stock has a potential upside of +9.52%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 7.1 9.5%